Medical Isotopes Research Center, Peking University, Beijing 100191, China.
Curr Pharm Biotechnol. 2010 Sep 1;11(6):610-9. doi: 10.2174/138920110792246546.
Molecular imaging provides a powerful tool for early disease detection, characterization, and real-time monitoring of therapeutic responses. Central to molecular imaging is the development of imaging probes. Receptors that are overexpressed in tumors have been potential targets for cancer imaging using targeted molecular probes. Since many cancer types simultaneously overexpress several receptors, the design of dual receptor-targeted molecular imaging probes has recently been proposed. Peptide heterodimers, and microbubble-based dual-targeted probes have shown especially good performance for in vivo cancer imaging. The success of these molecular probes demonstrates that the dual-targeting strategy is generally a good approach for developing molecular probes. In this review, we will introduce the current state of development of dual-targeted molecular imaging probes and summarize the various dual-targeted molecular probes for in vivo cancer imaging.
分子成像是一种强大的工具,可用于早期疾病检测、特征描述以及治疗反应的实时监测。分子成像的核心是成像探针的开发。在肿瘤中过度表达的受体已成为使用靶向分子探针进行癌症成像的潜在目标。由于许多癌症类型同时过度表达几种受体,因此最近提出了设计双受体靶向分子成像探针的方法。肽杂种二聚体和基于微泡的双靶向探针在体内癌症成像中表现出特别好的性能。这些分子探针的成功证明了双靶向策略通常是开发分子探针的一种好方法。在这篇综述中,我们将介绍双靶向分子成像探针的最新发展状况,并总结用于体内癌症成像的各种双靶向分子探针。